Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Completed · Early Phase 1

Conditions studied: Bladder Cancer, Radical Cystectomy, Urinary Bladder Neoplasms, Surgery

In brief

The purpose of this study is determine if using Impact Advanced Recovery® before and after RC surgery helps reduce surgical complications.

Key facts

Study ID

NCT01868087

Run by

Jill Hamilton-Reeves, PhD RD LD

People needed

30

Starts

2013-07-01

Expected to finish

2016-03-01

Last updated by the study team

2026-04-15

Who can join

Age: 40 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men undergoing RC surgery for primary bladder cancer

You may not qualify if…

• Patients with swallowing difficulties or unable to tolerate oral intake
• Evidence of metastatic disease
• Weight loss ≥ 10% (with respect to usual body weight) in the 6 months prior to surgery or BMI ≤ 18.5
• Patients undergoing cystectomy for non-bladder primary malignancy or cancer type other than urothelial
• Active viral infections such as Human immunodeficiency virus (HIV) positive, hepatitis, or who have a known immunodeficient state
• Prior history of gouty arthritis or uric acid stones
• Patients with milk, soy, or fish allergies

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.